Unicycive Therapeutics (UNCY) Interest Expenses (2020 - 2025)
Unicycive Therapeutics (UNCY) posted Interest Expenses of $27,000 for Q4 2025, up 35.0% from $20,000 a year earlier and up 80.0% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Interest Expenses (2020 - 2025) Analysis & Trends
For FY2025, Unicycive Therapeutics' Interest Expenses came in at $71,000, unchanged from FY2024.
- Annual Interest Expenses shows a five-year compound annual growth rate of -21.9% (FY2020 to FY2025).
- In prior years, Unicycive Therapeutics' Interest Expenses was $71,000 in FY2024 (-13.4%), $82,000 in FY2023, $6,000 in FY2022 (-99.0%) and $628,000 in FY2021 (+157.4%).
- The Q4 2025 figure stands as the highest quarterly Interest Expenses since Q2 2023.
- On a year-over-year basis, Interest Expenses increased in three of the last eight quarters, with an average decline of 0.4%.
- The strongest year-over-year quarter for Interest Expenses in the past five years was Q4 2023, with growth of 533.3%; the weakest was Q3 2022, with a decline of 94.5%.
- According to Business Quant data, Interest Expenses for the three prior quarters was $15,000 (Q3 2025), $13,000 (Q2 2025) and $15,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Unicycive Therapeutics | 109.75 Mn | -90.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Sep 30, 2021 | 55,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | 252,000.00 |
| Dec 31, 2020 | 163,000.00 |
| Sep 30, 2020 | 76,000.00 |
| Jun 30, 2020 | 2,000.00 |
API Access
Unicycive Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();